VA BENEFITS REFERENCE
DC 7719: Chronic Myelogenous Leukemia (CML) (Chronic Myeloid Leukemia Or Chronic Granulocytic Leukemia)
Read VA diagnostic code 7719 for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia): published criteria, regulatory notes, related codes and official sources checked October 25, 2026.
Published criteria from 38 CFR 4.117, current through 2026-10-22. Historical decisions may require a different version. This reference does not diagnose a condition or determine an evaluation.
The Hematologic and Lymphatic Systems · All Diagnostic Codes
DC 7719: Chronic Myelogenous Leukemia (CML) (Chronic Myeloid Leukemia Or Chronic Granulocytic Leukemia)
Diagnostic code 7719 addresses Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia). Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 7719 Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia): | |
| Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment | 100 |
| Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission | 60 |
| In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors | 30 |
| Note (1): If the condition undergoes leukemic transformation, evaluate as leukemia under diagnostic code 7703 | |
| Note (2): A 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant; or during the period of treatment with chemotherapy (including myelosuppressants). Six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105 of this chapter | |
What The Criteria Measure
- Does the decision identify diagnostic code 7719, and does the medical record describe the condition named by this code?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
Related Public DBQs
Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.
Regulatory Cross-References
Shared Rules And Regulatory Context
Context provisions do not create an additional evaluation automatically assigned to every condition.
Related Guides
Official Sources
Last verified 2026-10-25. Source publication or legal effective dates are shown separately where available.
Check The Source. Get Accredited Help.
Use this resource to understand published information. VA and the official decision control individual benefits.